A prospective, randomized and double blind once-monthly oral Ibandronate and Risedronate in post-menopausal osteoporosis leprosy patients

Journal Title: International Journal of Biomedical and Advance Research - Year 2017, Vol 8, Issue 11

Abstract

Objectives: The aim of the current investigation was to compare relative efficacy, tolerability and adherence of once monthly regimen of oral Ibandronate and Risedronate in postmenopausal osteoporotic leprosy patients with its impact on severity of the disease and quality of life. Method:This double blind, comparative study was conducted among 200 postmenopausal osteoporotic leprosy patients. The enrolled participants were screened for various diagnostic parameters. The participants were randomized in a 1:1 ratio to receive either oral Ibandronate (150 mg single tablet- once monthly) or oral Risedronate (150 mg single tablet- once monthly) for a period of one year. Results: Present study showed that treatment with both Ibandronate and Risedronate increased hip BMD, and Z-test with repeated measurements was used to examine the significance of the longitudinal changes in the BMD. The difference in the efficacy of the two drugs in increasing hip BMD might be attributed to the greater efficacy of Ibandronate in reducing bone turnover than that of Risedronate. Conclusion: Once monthly Ibandronate has a potential to decrease the severity of osteoporosis as compared to once monthly Risedronate. Also, the quality of life in terms of general health status, physical activity and pain, limitation in daily activity and the emotional status in postmenopausal osteoporotic leprosy patients is better with Ibandronate than that of Risedronate.

Authors and Affiliations

Shailesh Nagpure, Ranjana Kale, Swanand Pathak, Satyavan Patel

Keywords

Related Articles

Clinical Outcome of Emergency Laparotomy: Our Experience at tertiary care centre (A case series)

Introduction: Laparotomy is broadly used for any surgery requiring opening of abdominal wall and exploration of the underlying structures. Elective laparotomy indirectly implies that there is ample time for preoperative...

Tocotrienol Rich Fraction supplementation increased the antioxidant enzymes activities in skeletal and heart muscle of aging mice

Aging is initiated from free radical reactions which interrupted the antioxidant/prooxidant balance and consequently causing aging-related disease. Tocotrienol Rich Fraction (TRF) has been reported as a potent antioxidan...

A Study of Maternal Outcome in Uterine Rupture in Pregnancy at a Tertiary Care Institute

Aim and Objective: The present research was carried out with an objective to determine the incidence, etiology, trend, and management, maternal and fetal outcome of ruptured uterus and to identify the preventive measures...

Mean Platelet Volume in Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus - A Marker of Cardiovascular Risk

Background: Non- alcoholic fatty liver disease (NAFLD) is a common liver disease associated with diabetes and cardiovascular risk. Platelets play a vital role in hemostasis and mean platelet volume (MPV) is a measure of...

Diabetic foot ulcers and biofilm formation- The culprits

India leads the world with largest number of diabetic subjects earning the dubious distinction of being termed the diabetes capital of the world. DFIs are predominantly polymicrobial caused by a combination of Gram posit...

Download PDF file
  • EP ID EP384507
  • DOI 10.7439/ijbar.v8i11.4474
  • Views 89
  • Downloads 0

How To Cite

Shailesh Nagpure, Ranjana Kale, Swanand Pathak, Satyavan Patel (2017). A prospective, randomized and double blind once-monthly oral Ibandronate and Risedronate in post-menopausal osteoporosis leprosy patients. International Journal of Biomedical and Advance Research, 8(11), 407-415. https://europub.co.uk/articles/-A-384507